Carlsquare strengthens Healthcare team with Elisa Patricia Suhl as Director

Carlsquare is continuing to expand its expertise in Healthcare and Life Sciences. Elisa Patricia Suhl has joined the firm as a Director based in Munich. She brings more than ten years of M&A experience and advises companies and investors in the healthcare sector.

Elisa Patricia was most recently Head of M&A at hg medical, a contract developer and manufacturer of orthopaedic implants and a portfolio company of Astorg, a leading European private equity firm. Previously, she gained extensive experience in M&A and Debt Advisory in Frankfurt and London, most recently as Director Healthcare at Alantra. In this role, she advised private equity investors and companies on numerous buy-side and sell-side transactions. Suhl studied Finance and Corporate Finance at EBS University of Business and Law in Oestrich-Winkel and at Bayes Business School in London.

At Carlsquare, Elisa Patricia will work closely with Managing Partner Caspar Graf Stauffenberg. Carlsquare’s Healthcare and Life Sciences team comprises around ten M&A professionals based in Munich and Boston. The firm advises clients in the healthcare sector, particularly in medical technology and medical devices, pharmaceuticals, contract services for medical technology and pharmaceuticals, healthcare providers and service companies, as well as software and digital business models.

Recent Healthcare transactions advised on by Carlsquare include the sale of curea medical to Mérieux Equity Partners, Schwabe Group’s strategic investment in NeuroNation, the sale of vitagroup’s Health Dialog business unit to Legian Investment Partner, and the growth financing of radiopharmaceutical manufacturer and contract manufacturer ROTOP Pharmaka by GENUI and SHS Capital.

“We are delighted to welcome Elisa Patricia Suhl to Carlsquare. She combines many years of M&A experience with in-depth Healthcare expertise and understands the perspectives of companies, entrepreneurs and investors. Together with her, we aim to further expand our advisory capabilities in the Healthcare and Life Sciences markets,” says Caspar Graf Stauffenberg, Managing Partner at Carlsquare.

“Particularly in the mid-market, the Healthcare sector offers numerous growth and consolidation opportunities. Entrepreneurs and investors need an adviser who understands the sector’s strategic, regulatory and financial characteristics and can support transactions across borders. With its sector expertise and international network, Carlsquare offers an excellent platform for this,” says Elisa Patricia Suhl.

Carlsquare is a partner-led M&A advisory firm focused on technology and growth companies. The firm advises on around 50 transactions each year involving private equity investors and employs more than 180 people across 12 offices in Europe and the United States.